Lv414
710 积分 2024-11-07 加入
Atomic-scale modeling of C/N kinetic stability descriptors for PGM-free electrocatalysts at finite temperatures
9天前
已完结
Theoretical study of the strain effect on the oxygen reduction reaction activity and stability of FeNC catalyst
9天前
已完结
Pressure welding methods
19天前
已完结
Why shouldn’t double-layer capacitance (Cdl) be always trusted to justify Faradaic electrocatalytic activity differences?
20天前
已完结
Structural engineering of Fe single-atom oxygen reduction catalyst with high site density and improved mass transfer
20天前
已完结
57Fe-Mössbauer spectroscopy and basic interpretation of Mössbauer parameters
25天前
已完结
Does the 57Fe Mössbauer isomer shift depend on the oxidation state of iron?
25天前
已完结
Design and assessment of electrochemical carbonate-to-ethylene processes
26天前
已完结
A new strategy of preparing high-value products by co-pyrolysis of bamboo and ZIF-8
27天前
已完结
Size-controlled synthesis of ZIF-8 particles and their pyrolytic conversion into ZnO aggregates as photoanode materials of dye-sensitized solar cells
27天前
已完结
Spatial mapping of transcriptomic plasticity in metastatic pancreatic cancer
6天前
已采纳
Tailoring 2D Heteroatom‐Doped Carbon Nanosheets with Dominated Pseudocapacitive Behaviors Enabling Fast and High‐Performance Sodium Storage
6天前
已采纳
Spectroscopic Properties and Reactivity of a MnIII‐hydroperoxo Complex that is Stable at Room Temperature
12天前
已采纳
Deboronative functionalization of alkylboron species via a radical-transfer strategy
12天前
已采纳
Insect-scale fast moving and ultrarobust soft robot
18天前
已采纳
Charge carrier management via semiconducting matrix for efficient self-powered quantum dot infrared photodetectors
19天前
已驳回
Reprogramming site-specific retrotransposon activity to new DNA sites
19天前
已采纳
Injectable Anti‐Inflammatory Supramolecular Nanofiber Hydrogel to Promote Anti‐VEGF Therapy in Age‐Related Macular Degeneration Treatment
20天前
已采纳
Co-Doped MoS2 Nanosheets with the Dominant CoMoS Phase Coated on Carbon as an Excellent Electrocatalyst for Hydrogen Evolution
20天前
已采纳
Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials
20天前
已采纳
皖公网安备34019202002308
